CARLSBAD, Calif., March 21,
2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.
(Nasdaq: IONS) today announced that management will present at the
following investor conferences:
- Stifel 2022 Virtual CNS Days on Monday,
March 28, 2022
- Guggenheim Virtual Genomic Medicines and Rare Disease Day on
Friday, April 1, 2022
- Needham 21st Annual Virtual Healthcare Conference on
Monday, April 11, 2022
- Bank of America 2022 Healthcare Conference on Wednesday, May 11, 2022, in Las Vegas, NV
A live webcast and additional information about each
presentation can be accessed on the Investors & Media section
of the Ionis website at www.ionispharma.com. Replays will be
available on the Ionis website within 48 hours of each event.
About Ionis
Pharmaceuticals
For more than 30 years, Ionis has been the leader in
RNA-targeted therapy, pioneering new markets and changing standards
of care with its novel antisense technology. Ionis currently has
three marketed medicines and a premier late-stage pipeline
highlighted by industry-leading neurological and cardiometabolic
franchises. Our scientific innovation began and continues with the
knowledge that sick people depend on us, which fuels our vision of
becoming a leading, fully-integrated biotechnology company.
To learn more about Ionis visit www.ionispharma.com and
follow us on twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301505979.html
SOURCE Ionis Pharmaceuticals, Inc.